Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of 'eye stroke' (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

Abstract: Cardiac autonomic Neuropathy (CAN) is an acute complication of Diabetes mellitus (DM) that does not exhibit overt symptoms in the subclinical stage. Researchers have developed several ...

Introduction Cardiovascular autonomic neuropathy (CAN) is a serious, untreatable complication of diabetes that contributes to excess cardiovascular mortality and morbidity. CAN is associated with ...

Objectives The aims of this study were to investigate circulating levels of inflammatory markers in adolescents with type 1 diabetes with and without different types of neuropathies and evaluate the ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...

Forty individuals with T2D (aged 45–75) with varying degrees of CAN and 20 age-matched controls were included in this cross-sectional study. Autonomic profiling included cardiovascular autonomic ...

In patients with cardiac autonomic neuropathy, intensive glycemic treatment decreases risk for CV events and mortality. Intensive glycemic treatment decreases cardiovascular and mortality risk in ...

Background: Patients with chronic kidney disease (CKD) are at higher risk of cardiovascular disease. A dysfunctional autonomic nervous system may be the underlying cause. However, very few studies ...

Women with cardiovascular autonomic neuropathy and type 2 diabetes have increased risk of mortality. Mortality is associated with cardiovascular autonomic neuropathy (CAN) among women with type 2 ...